KalVista Highlights Real-World Data on HAE Treatments and Patient Experiences at EAACI Congress
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV), today announced that it presented real-world data from US patient surveys that assessed the experience of HAE patients using injectable on-demand treatments at the European